Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.

DUSA

Davis Select US Equity (DUSA)

Davis Select US Equity
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:DUSA
FechaHoraFuenteTítuloSímboloCompañía
05/03/202112:00Business WireDavis ETFs to Transfer Exchange Listing of All Four Funds to CBOE Global Markets, Inc.NASDAQ:DUSADavis Select US Equity
12/06/202011:22Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:DUSADavis Select US Equity
17/01/201808:18Business WireDavis Advisors Celebrates One Year Anniversary of Davis Actively Managed Equity ETFsNASDAQ:DUSADavis Select US Equity
13/04/201709:00GlobeNewswire Inc.The Nasdaq Stock Market® Welcomes Seven New ETPs in the First Quarter of 2017NASDAQ:DUSADavis Select US Equity
12/04/201709:29GlobeNewswire Inc.Davis Advisors to Ring The Nasdaq Stock Market Opening BellNASDAQ:DUSADavis Select US Equity
12/01/201707:00Business WireDavis Advisors Launches Three Transparent Actively Managed Equity ETFsNASDAQ:DUSADavis Select US Equity
20/12/201216:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DUSADavis Select US Equity
20/12/201216:38Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:DUSADavis Select US Equity
20/12/201215:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:DUSADavis Select US Equity
20/12/201215:54Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:DUSADavis Select US Equity
20/12/201215:50Edgar (US Regulatory)(25-NSE)NASDAQ:DUSADavis Select US Equity
20/12/201213:05Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:DUSADavis Select US Equity
20/12/201213:05Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:DUSADavis Select US Equity
20/12/201207:00PR Newswire (US)Caraco Pharmaceutical Laboratories Announces Successful Tender Offer To Acquire DUSANASDAQ:DUSADavis Select US Equity
14/12/201215:59Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:DUSADavis Select US Equity
14/12/201214:47Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(b)) (485bpos)NASDAQ:DUSADavis Select US Equity
14/12/201214:47Edgar (US Regulatory)(40-17F2)NASDAQ:DUSADavis Select US Equity
14/12/201214:47Edgar (US Regulatory)Post-effective Amendment (investment Company, Rule 485(a)) (485apos)NASDAQ:DUSADavis Select US Equity
14/12/201214:46Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DUSADavis Select US Equity
14/12/201214:46Edgar (US Regulatory)Current report filing (8-K)NASDAQ:DUSADavis Select US Equity
05/12/201211:00GlobeNewswire Inc.Caraco Pharmaceutical Laboratories and DUSA Pharmaceuticals Announce Early Termination of the Hart-Scott-Rodino Waiting PeriodNASDAQ:DUSADavis Select US Equity
21/11/201215:57Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:DUSADavis Select US Equity
21/11/201215:57Edgar (US Regulatory)Statement of Ownership: Solicitation (SC 14D9)NASDAQ:DUSADavis Select US Equity
21/11/201215:03Edgar (US Regulatory)Tender offer statement by Third Party (SC TO-T)NASDAQ:DUSADavis Select US Equity
21/11/201215:03Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:DUSADavis Select US Equity
20/11/201215:33Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:DUSADavis Select US Equity
20/11/201215:33Edgar (US Regulatory)Written communication by the subject company relating to a third party tender offer (SC14D9C)NASDAQ:DUSADavis Select US Equity
19/11/201216:27Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:DUSADavis Select US Equity
19/11/201216:27Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:DUSADavis Select US Equity
19/11/201216:13Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:DUSADavis Select US Equity
 Showing the most relevant articles for your search:NASDAQ:DUSA